An Elderly Patient with Chronic Hyponatremia

被引:18
作者
Berl, Tomas [1 ]
机构
[1] Univ Colorado, Div Renal Dis & Hypertens, Aurora, CO 80045 USA
来源
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2013年 / 8卷 / 03期
关键词
ORAL TOLVAPTAN; HORMONE; EFFICACY; SECRETION; ETIOLOGY; FRACTURE; SAFETY; RISK;
D O I
10.2215/CJN.03100312
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Hyponatremia is the most common electrolyte disorder. With the aging of the population and the greater propensity of the elderly to develop hyponatremia, this electrolyte disorder is of increasing importance to the practicing nephrologist. In this Attending Rounds, an illustrative patient with hyponatremia is presented. The reasons for the increased incidence and prevalence of hyponatremia in the elderly are discussed, with emphasis on the effects of aging on urinary dilution, the frequently multifactorial nature of hyponatremia in this population, and the absence of a definite cause for inappropriate and persistent vasopressin release in many such patients. The rationale for treating the hyponatremia, even when apparently asymptomatic, is discussed, with attention to cognitive function, gait, and bone structure disturbances that increase the risk for fractures. The various available treatment approaches, including water restriction, demeclocycline, loop diuretics with NaCl supplementation, urea, and vasopressin antagonists are summarized, with emphasis on the efficacy and limitations of each of these therapies. Clin J Am Soc Nephrol 8: 469-475, 2013. doi: 10.2215/CJN.03100312
引用
收藏
页码:469 / 475
页数:7
相关论文
共 30 条
[1]   Roles of glutamine in neurotransmission [J].
Albrecht, Jan ;
Sidoryk-Wegrzynowicz, Marta ;
Zielinska, Magdalena ;
Aschner, Michael .
NEURON GLIA BIOLOGY, 2010, 6 (04) :263-276
[2]   Osteoclast Response to Low Extracellular Sodium and the Mechanism of Hyponatremia-induced Bone Loss [J].
Barsony, Julia ;
Sugimura, Yoshihisa ;
Verbalis, Joseph G. .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2011, 286 (12) :10864-10875
[3]  
Berl T, 2008, J AM SOC NEPHROL, V19, P1076, DOI 10.1681/ASN.2007091042
[4]   Oral Tolvaptan Is Safe and Effective in Chronic Hyponatremia [J].
Berl, Tomas ;
Quittnat-Pelletier, Friederike ;
Verbalis, Joseph G. ;
Schrier, Robert W. ;
Bichet, Daniel G. ;
Ouyang, John ;
Czerwiec, Frank S. .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2010, 21 (04) :705-712
[5]  
CAIRD FI, 1973, BRIT HEART J, V35, P527
[6]  
CLARK BA, 1994, J AM SOC NEPHROL, V5, P1106
[7]   Severe hyponatraemia in medical in-patients: aetiology, assessment and outcome [J].
Clayton, J. A. ;
Le Jeune, I. R. ;
Hall, I. P. .
QJM-AN INTERNATIONAL JOURNAL OF MEDICINE, 2006, 99 (08) :505-511
[8]   TREATMENT OF THE SYNDROME OF INAPPROPRIATE SECRETION OF ANTI-DIURETIC HORMONE WITH FUROSEMIDE [J].
DECAUX, G ;
WATERLOT, Y ;
GENETTE, F ;
MOCKEL, J .
NEW ENGLAND JOURNAL OF MEDICINE, 1981, 304 (06) :329-330
[9]   EFFECTS OF DEMETHYLCHLORTETRACYCLINE ON CELLULAR ACTION OF ANTIDIURETIC-HORMONE INVITRO [J].
DOUSA, TP ;
WILSON, DM .
KIDNEY INTERNATIONAL, 1974, 5 (04) :279-284
[10]   The Urine/Plasma electrolyte ratio: A predictive guide to water restriction [J].
Furst, H ;
Hallows, KR ;
Post, J ;
Chen, S ;
Kotzker, W ;
Goldfarb, S ;
Ziyadeh, FN ;
Neilson, EG .
AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2000, 319 (04) :240-244